| Patents for C07K - Peptides (3,738) |
|---|
| 03/10/2005 | WO2005021578A2 A novel chimeric polypeptide and use thereof |
| 03/10/2005 | WO2005021577A2 Novel plant glycine and histidinie-rich metal-binding protein family and uses thereof |
| 03/10/2005 | WO2005021576A2 Methods for for modeling gpcrs and for producing ligand blocking and receptor activating antibodies for same |
| 03/10/2005 | WO2005021575A2 Bacterial signaling molecules that down-regulate pathogenic bacterial virulence properties |
| 03/10/2005 | WO2005003162A3 An endogenous peptide and active subfragments thereof |
| 03/10/2005 | WO2004081031A3 Thiol-mediated drug attachment to targeting peptides |
| 03/10/2005 | US20050054573 Kit for detection, monitoring kinase, phosphatase; mixture of peptides; detectable compound; adjustment proteolytic sensitivity |
| 03/09/2005 | CN1590551A Optimization of cell for endogenous gene activation |
| 03/03/2005 | WO2005019242A2 Recombinant expression of the hag1 antimicrobial peptide: use as fusion partner for the expression of alpha helical antimicrobial peptides |
| 03/03/2005 | WO2005019241A2 Cationic antimicrobial peptides and compositions thereof |
| 03/03/2005 | WO2005019240A2 Melanin concentrating hormone receptor antagonists |
| 03/03/2005 | WO2005019239A2 Car ligand-binding domain polypeptide co-crystallized with a ligand, and methods of designing ligands that modulate car activity |
| 03/03/2005 | WO2004104019A3 Anti-inflammatory/anti-microbial peptides for use in dialysis |
| 03/03/2005 | WO2004083235A3 Tie-2 modulators and methods of use |
| 03/03/2005 | US20050050587 Inducers of plant disease resistance |
| 03/03/2005 | US20050048622 Neuregulin fusion comprising epidermal growth factor domain for use in treatment and prevention of nervous system and neurodegenerative disorders |
| 03/03/2005 | US20050048554 Surface coated with a film of alternating polycationic and polyanionic polymers (may contain polyelectrolyte-silica sol-gel film) for protein immobilization; solid phase synthesis; kits |
| 03/03/2005 | US20050048071 Short peptide associated with leukemia that induces immunology response; cancer vaccine; leukemia antigen |
| 03/03/2005 | US20050048057 Diagnosis, therapy of cancer, cardiovascular disorders, atherosclerosis, restenosis, osteoporosis, antiinflammatory agents |
| 02/24/2005 | WO2005016955A2 Nogo receptor antagonists |
| 02/24/2005 | WO2005016954A2 Immunologic activity measure(s) for t “helper” on-associated conditions |
| 02/24/2005 | WO2005016953A2 Antagonistic analogs of gh-rh (2003) |
| 02/24/2005 | WO2005016952A2 Polyvalent immunogen |
| 02/24/2005 | WO2005000872A3 Collagen mimics |
| 02/24/2005 | WO2004089972A3 Mass spectrometry data analysis techniques |
| 02/24/2005 | WO2004072099A3 Novel peptide inhibitor of hiv fusion that disrupts the internal trimeric coiled-coil of gp41 |
| 02/24/2005 | WO2004050684A3 Methods for improving secondary metabolite production in fungi |
| 02/24/2005 | US20050042635 Prophylactic and therapeutic benefits of a new class of immune stimulating peptides |
| 02/24/2005 | CA2535007A1 Nogo receptor antagonists |
| 02/24/2005 | CA2534436A1 Antagonistic analogs of gh-rh (2003) |
| 02/24/2005 | CA2526339A1 Polyvalent immunogen |
| 02/17/2005 | WO2005014780A2 Prostate stem cell antigen (psca) variants and subsequences thereof |
| 02/17/2005 | WO2005014619A2 Heparin-binding peptides and uses thereof |
| 02/17/2005 | WO2005014618A2 Bispecific antibodies for inducing apoptosis of tumor and diseased cells |
| 02/17/2005 | WO2005014617A2 Cyclic peptide compositions and methods for treatment of sexual dysfunction |
| 02/17/2005 | WO2005014616A2 Complexes of gpcr142 and relaxin3 or insl5, and their production and use |
| 02/17/2005 | WO2005014615A2 Self-assembling peptides incorporating modifications and methods of use thereof |
| 02/17/2005 | WO2004083236A3 Cancer treatment using proanp peptides |
| 02/17/2005 | WO2004014937A3 Thrombin peptide derivatives |
| 02/17/2005 | WO2004000872A3 Improved alphavirus vectors having attenuated virion structural proteins |
| 02/17/2005 | US20050038051 Novel molecules for regulating cell death |
| 02/17/2005 | US20050038009 1,1-dioxo-3,3-dibutyl-5-phenyl-7-methylthio-8-(N-{(R)- alpha -[N-((S)-1-carboxypropyl) carbamoyl]-4-hydroxybenzyl}carbamoylmethoxy)-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepine |
| 02/17/2005 | US20050037413 functionalized substrates bound to layers of dendrimers and to target-specific ligands, used in combinatorial chemistry, protein, nucleic acid or nucleic acid/peptide hybridization detection; medical diagnosis |
| 02/17/2005 | CA2534898A1 Bispecific antibodies for inducing apoptosis of tumor and diseased cells |
| 02/17/2005 | CA2534739A1 Complexes of gpcr142 and relaxin3 or insl5, and their production and use |
| 02/17/2005 | CA2530482A1 Self-assembling peptides incorporating modifications and methods of use thereof |
| 02/17/2005 | CA2526274A1 Prostate stem cell antigen (psca) variants and subsequences thereof |
| 02/16/2005 | CN1582165A Antibodies to CD40 |
| 02/16/2005 | CN1582151A Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibitory activity for the treatment hyperlipidaemia |
| 02/10/2005 | WO2005012330A2 AMYLOID β-PEPTIDE AND METHODS OF USE |
| 02/10/2005 | WO2005012329A2 Kinase and phosphatase assays |
| 02/10/2005 | WO2004067551A3 Method for identifying peptides by mass spectrometry |
| 02/09/2005 | EP1503794A1 Methods of treatement using ctla-4 antibodies |
| 02/03/2005 | WO2005010026A2 Methods for detecting activation of t-cells by mhc binding peptides |
| 02/03/2005 | WO2005010024A2 Potent peptide inhibitors and methods of use |
| 02/03/2005 | WO2005010023A2 Method for prediction of an epitope |
| 02/03/2005 | WO2005010022A2 Agonist polypeptide of receptor for zot and zonulin |
| 02/03/2005 | WO2004072102A3 Benzene acetamide compounds useful as serine protease inhibitors |
| 02/03/2005 | US20050026215 Method for the prediction of an epitope |
| 02/03/2005 | CA2531491A1 Agonist polypeptide of receptor for zot and zonulin |
| 02/02/2005 | EP0828754B1 Dipeptides which promote release of growth hormone |
| 02/02/2005 | CN1187369C Method for producing peptide salts. their use, and pharmaceutical prepns. containing these peptide salts |
| 02/01/2005 | US6849720 Monoclonal antibodies to the human LDL receptor, their production and use |
| 01/29/2005 | CA2445420A1 Kinase and phosphatase assays |
| 01/27/2005 | WO2005007678A2 Methods for the preparation of rhodamine |
| 01/27/2005 | WO2005007677A2 Affinity capture of peptides by microarray and related methods |
| 01/27/2005 | WO2005007676A2 Glycopeptides for the treatment of als and other metabolic and autoimmune disorders |
| 01/27/2005 | WO2005007675A2 TRIAZOLE ϵ-AMINO ACIDS |
| 01/27/2005 | WO2005007674A2 Anti-human vitronectin antibody and methods for making the same |
| 01/27/2005 | WO2005007673A2 Immunogenic peptides |
| 01/27/2005 | WO2005007672A2 Small molecule toll-like receptor (tlr) antagonists |
| 01/27/2005 | WO2005007671A2 Compositions and methods for treating sars |
| 01/27/2005 | WO2004094460A3 Polypeptides related to natriuretic peptides and methods of their identification and use |
| 01/27/2005 | US20050020500 Glycosaminoglycan-polypeptide complex; antiarthritic agents |
| 01/27/2005 | US20050019847 Using preferential antibodies to identify ubiquitin-like protein (ISG15); immunodiagnostics; wound healing agents |
| 01/27/2005 | US20050019346 Nucleic acids and regulatory sequences; gene expression; antitumor agents |
| 01/27/2005 | CA2528774A1 Small molecule toll-like receptor (tlr) antagonists |
| 01/20/2005 | WO2005005456A2 Peptide deformylase inhibitors |
| 01/20/2005 | WO2004083232A3 Receptor proteins |
| 01/19/2005 | CN1565627A Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 01/19/2005 | CN1185257C Glucagon insulinotropic complexes, compositions and methods |
| 01/18/2005 | CA2269638C Ice inhibiting peptides |
| 01/13/2005 | WO2005003162A2 An endogenous peptide and active subfragments thereof |
| 01/13/2005 | WO2005003150A2 Compositions and methods for use of a protease inhibitor and adenosine for preventing organ ischemia and reperfusion injury |
| 01/13/2005 | US20050009748 Compositions for delivering peptide YY and PYY agonists |
| 01/13/2005 | US20050009150 Humanized antibodies that recognize beta amyloid peptide |
| 01/13/2005 | US20050009147 Parathyroid hormone variants; site-directed mutagenesis; for treatment of bone disorders |
| 01/13/2005 | US20050009050 Detecting and quantifies analytes by forming an analyte-specific amplicon through the interaction of single stranded DNA and antibody; high throughput assay |
| 01/13/2005 | CA2531240A1 An endogenous peptide and active subfragments thereof |
| 01/13/2005 | CA2531062A1 Compositions and methods for use of a protease inhibitor and adenosine for preventing organ ischemia and reperfusion injury |
| 01/06/2005 | WO2005000872A2 Collagen mimics |
| 01/06/2005 | WO2005000871A2 Peptides antagonistic to an anti-angiogenic antibody and uses therefor |
| 01/06/2005 | WO2005000870A2 Isolated ny-eso-1 peptides which bind to hla class ii molecules and uses thereof |
| 01/06/2005 | WO2004076474A3 Polyethylene glycol modified interferon compositions and methods of use thereof |
| 01/06/2005 | WO2004074312A3 Tryptophyllin peptides and uses thereof |
| 01/06/2005 | US20050004032 COMPRISING TRIPEPTIDE UNIT OF THE FORMULA (flp-Yaa-Gly)N, WHERE Yaa IS ANY AMINO ACID, FLP IS 4(R)-FLUORO-L-PROLINE, AND N IS AT LEAST 3; INCREASED STABILITY; STRONGER TRIPLE HELIX THAN NATIVE COLLAGEN; FOR USE SUCH AS IN ARTIFICIAL SKIN |
| 01/06/2005 | US20050004013 Selective R-cadherin antagonist and methods |
| 01/06/2005 | US20050003457 Immunoglobulin which binds osteoclastogenesis inhibitory factor binding molecules (OBM)) and prevents bone resorption for use in treatment and prevention of bone disorders |
| 01/06/2005 | US20050003397 Peptide useful in immunomodulation |
| 01/05/2005 | EP1493751A1 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |